ODEVIXIBAT Pharmacologic Class Indexing
- Class set ID
- 9d80c728-2ed3-4a1f-b196-b449646be26d
- Version
- 1
- Effective date
- 20211129
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use BYLVAY safely and effectively. See full prescribing information for BYLVAY. BYLVAY (odevixibat) capsules, for oral use BYLVAY (odevixibat) oral pellets Initial U.S. Approval: 2021 | Albireo Pharma, Inc. | Syngene International Limited. | Patheon France SAS | Almac Pharma Services Limited | AndersonBrecon Inc. (PCI Pharma Services) | 20251231 | 9 |
| These highlights do not include all the information needed to use BYLVAY safely and effectively. See full prescribing information for BYLVAY. BYLVAY (odevixibat) capsules, for oral use BYLVAY (odevixibat) oral pellets Initial U.S. Approval: 2021 | Ipsen Biopharmaceuticals, Inc. | Syngene International Limited. | Almac Pharma Services Limited | 20251229 | 4 |